Cloned (Comment) | Organism |
---|---|
DNA and amino acid sequence determination and analysis, phylogenetic analysis, cloning of enzyme sHS, and recombinant expression of His-tagged enzyme in Escherichia coli strain BL21 pLysS | Penaeus vannamei |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Penaeus vannamei | |
Mn2+ | required | Penaeus vannamei |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Penaeus vannamei | - |
- |
- |
Purification (Comment) | Organism |
---|---|
recombinant His-tagged enzyme from Escherichia coli strain BL21 pLysS | Penaeus vannamei |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | substrate specificity analysis, overview. For the heparin polysaccharides, derived from porcine intestinal mucosa heparin, sulfate groups are incorporated into glucosamine residues containing both N-sulfated and N-acetylated substitution within the regions of the predominant repeating disaccharide, either I-ANS or I-ANAc. But the resulting polysaccharides do not stabilize antithrombin, which is correlated with anticoagulant activity. The enzyme is able to sulfate disaccharides, I2S-ANS and G-ANAc. 3-O-sulfation can be induced outside of the classical heparin-binding pentasaccharide sequence. Product analysis by NMR spectroscopy, and antithrombin stabilization analysis by differential scanning fluorimetry (DSF). Only chemically modified heparins served as substrates for sHs whereas chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate and hyaluronic acid do not. Also N-desulfated-N-reacetylated heparin is not modified by sHS. Acceptor substrates are HS, heparin (Hep), modified heparin: O,N-desuIfated-N-reacetylated (HepNAc), and O,N-desuIfated-N-resuIfated (HepNSuIfo). Enzyme sHS does not require either 2-O-, 6-O- or N-sulfate in heparin/HS to modify the polymer and, N-acetylation does not block 3-O-sulfation as anticipated by the hierarchical biosynthetic process where 3-O-sulfation would happen as the final modification step. The data shows that 3-O-sulfation can occur in distinct biosynthetic steps either being the last HS sulfotransferase in the biosynthesis process or the first one in a non-hierarchical way, according to the oligosaccharides tested | Penaeus vannamei | ? | - |
- |
Synonyms | Comment | Organism |
---|---|---|
3-O-sulfotransferase | - |
Penaeus vannamei |
SHS | - |
Penaeus vannamei |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Penaeus vannamei |
Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|
100 | - |
purified recombinant enzyme, 1 min, pH 7.0, inactivation | Penaeus vannamei |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7 | - |
assay at | Penaeus vannamei |
General Information | Comment | Organism |
---|---|---|
evolution | significant structural similarity between sHs and the human heparan sulfate 3-O-suIfotransferase isoform 5, phylogenetic analysis. The enzyme from Litopenaeus vannamei belongs to the O-sulfotransferase family | Penaeus vannamei |
metabolism | role of 3-O-sulfotransferase in heparan sulfate biosynthesis. 3-O-sulfation can occur in distinct biosynthetic steps either being the last HS sulfotransferase in the biosynthesis process or the first one in a non-hierarchical way, according to the oligosaccharides tested | Penaeus vannamei |
physiological function | role of 3-O-sulfotransferase in heparan sulfate biosynthesis. 3-O-sulfation can be induced outside of the classical heparin-binding pentasaccharide sequence, and 3-O-sulfation of glucosamine is not a sufficient condition for antithrombin stabilization and suggest that the use of this enzyme during haparan sulfate (HS) biosynthesis may not occur as the final enzymatic step. Thermostabilizing effects of sHS-treated heparins on antithrombin | Penaeus vannamei |